![](/Jwk_zgyxzz/develop/static/common/images/pdf.png)
Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China
ZHAO Xue, SUN Li-hua
Chinese Pharmaceutical Journal ›› 2016, Vol. 51 ›› Issue (21) : 1895-1900.
Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|